Form 4 for PODD Insulet Corporation
Accepted 2022-11-07 00:00:00 ET · period of report 2022-11-04 · accession 0001127602-22-025027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-07 | 2022-11-04 | PODD | Spears Michael P | SVP, RA, Compliance | M - OptEx | $46.22 | +6,290 | 22.4K | +39% | +$290.7K |
| D | 2022-11-07 | 2022-11-04 | PODD | Spears Michael P | SVP, RA, Compliance | S - Sale+OE | $308.99 | -13.7K | 8,792 | -61% | -$4.22M |
| D | 2022-11-07 | 2022-11-04 | PODD | Spears Michael P | SVP, RA, Compliance | M - OptEx | $0.00 | -6,290 | 10.8K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-04 | M | A | 6,290 | $46.22 | 22,450 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. |
| 2 | Common | Common Stock | 2022-11-04 | S | D | 13,658 | $308.99 | 8,792 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. (F2) The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $306.38 to $320. Specifically:7,368 shares were sold at a price of $306.38; 5,000 shares were sold at a price of $310; and 1,290 shares were sold at a price of $320. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2022-11-04 | M | D | 6,290 | $0.00 | 10,768 | D | $46.22 · — to 2027-02-22 | 6,290 Common Stock | (F3) This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |